BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol 2005; 11(18): 2773-2776 [PMID: 15884120 DOI: 10.3748/wjg.v11.i18.2773]
URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2773.htm
(0) (0) (5659) (46)
Number Citing Articles
1
Giovanni Latella, Carmelo Scarpignato. Rifaximin in the management of colonic diverticular disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6) doi: 10.1586/egh.09.63
2
V. L. Martynov, A. Kh. Khairdinov. THE ETHIOPATOGENESIS AND THE ANALYSIS OF AN ANTIBIOTIC TREATMENT OF A SMALL INTESTINE BACTERIAL OVERGROWTH SYNDROME. Bulletin of Siberian Medicine 2015; 14(3) doi: 10.20538/1682-0363-2015-3-49-62
3
R. D'INCÀ, F. POMERRI, M. G. VETTORATO, E. DAL PONT, V. DI LEO, A. FERRONATO, V. MEDICI, G. C. STURNIOLO. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Alimentary Pharmacology & Therapeutics 2007; 25(7) doi: 10.1111/j.1365-2036.2007.03266.x
4
Qaim Shah, Jonathan Soldera. Exploring effectiveness of Metronidazole, Bismuth, and Rifaximin in treating small intestinal bacterial overgrowth and irritable bowel syndrome: A systematic review. World Journal of Methodology 2026; 16(1): 107169 doi: 10.5662/wjm.v16.i1.107169
5
L. Gatta, C. Scarpignato. Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Alimentary Pharmacology & Therapeutics 2017; 45(5) doi: 10.1111/apt.13928
6
Hassan Al Harakeh, Abhilash J. Paily, Samer Doughan, Irshad Shaikh. Recurrent Acute Diverticulitis: When to Operate?. Inflammatory Intestinal Diseases 2018; 3(2) doi: 10.1159/000494973
7
Sergio Peralta, Claudia Cottone, Tiziana Doveri, Piero Luigi Almasio, Antonio Craxi. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin. World Journal of Gastroenterology 2009; 15(21): 2628-2631 doi: 10.3748/wjg.15.2628
8
Chia-Chang Chen, Jiann-Sheng Su, Hong-Zen Yeh, Chi-Sen Chang, Yen-Chun Peng, Chih-Wei Tseng, Yu-Tso Chen, Cheng-Li Lin, Chia-Hung Kao. Association Between Colonic Diverticulosis and Erectile Dysfunction. Medicine 2015; 94(47) doi: 10.1097/MD.0000000000002042
9
Antonio Tursi. New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opinion on Pharmacotherapy 2007; 8(3) doi: 10.1517/14656566.8.3.299
10
Thomas R. Ziegler, Conrad R. Cole. Small bowel bacterial overgrowth in adults: A potential contributor to intestinal failure. Current Gastroenterology Reports 2007; 9(6) doi: 10.1007/s11894-007-0060-x
11
Francesca Romana Ponziani, Viviana Gerardi, Antonio Gasbarrini. Diagnosis and treatment of small intestinal bacterial overgrowth. Expert Review of Gastroenterology & Hepatology 2016; 10(2) doi: 10.1586/17474124.2016.1110017
12
Michel Bouchoucha, Marinos Fysekidis, Céline Lekhal, Bakhtiar Daniel Bejou, Jean-Marc Sabate, Robert Benamouzig. COLIGENTA treatment of small intestinal bacterial overgrowth. Results of an open study.. Digestive and Liver Disease 2021; 53(1) doi: 10.1016/j.dld.2020.10.032
13
Julius Špičák, Miloš Kučera, Gabriela Suchánková. Diverticular disease: diagnosis and treatment. Vnitřní lékařství 2018; 64(6) doi: 10.36290/vnl.2018.086
14
Carmelo Scarpignato, Anna Bertelé, Antonio Tursi. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1) doi: 10.1097/MCG.0000000000000641
15
Sarah Khan, Lin Chang. Diagnosis and management of IBS. Nature Reviews Gastroenterology & Hepatology 2010; 7(10) doi: 10.1038/nrgastro.2010.137
16
Danielle Harari. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 2010;  doi: 10.1016/B978-1-4160-6231-8.10108-4
17
Tsumugi Jono, Yuki Kasai, Takaomi Kessoku, Kosuke Tanaka, Michihiro Iwaki, Takashi Kobayashi, Kota Takahashi, Kosuke Seita, Takayuki Kato, Eiji Sakai, Takeo Kurihashi, Machiko Nakatogawa, Shunsuke Oyamada, Seiji Futagami, Kok-Ann Gwee, Atsushi Nakajima, Antonio Tursi. Patients with symptomatic uncomplicated diverticular disease have high fecal bile acid concentrations. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1533644
18
Jessica Cottreau, Shannon F Baker, Herbert L DuPont, Kevin W Garey. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Review of Anti-infective Therapy 2010; 8(7) doi: 10.1586/eri.10.58
19
E.-M. Schmidt, R. Jakobs. Divertikulose und Divertikulitis im Alter. Der Gastroenterologe 2012; 7(4) doi: 10.1007/s11377-012-0660-3
20
H. J. Heppner. Spezifische Aspekte bei Infektionserkrankungen im Alter. Der Gastroenterologe 2021; 16(5) doi: 10.1007/s11377-021-00548-w
21
Erica Cohen, Garth Fuller, Roger Bolus, Rusha Modi, Michelle Vu, Kamyar Shahedi, Rena Shah, Mary Atia, Nicole Kurzbard, Victoria Sheen, Nikhil Agarwal, Marc Kaneshiro, Linnette Yen, Paul Hodgkins, M. Haim Erder, Brennan Spiegel. Increased Risk for Irritable Bowel Syndrome After Acute Diverticulitis. Clinical Gastroenterology and Hepatology 2013; 11(12) doi: 10.1016/j.cgh.2013.03.007
22
Carmelo Scarpignato, Neil Stollman. Colonic Diverticular Disease. 2022;  doi: 10.1007/978-3-030-93761-4_18
23
Nayoung Kim. The Relationship of Dysbiosis of Duodenal Microbiome and Functional Dyspepsia. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2024; 24(4) doi: 10.7704/kjhugr.2024.0053
24
Antonio Tursi. Colonic microflora imbalance and diverticular disease. Digestive and Liver Disease 2010; 42(6) doi: 10.1016/j.dld.2009.09.003
25
Lisa L Strate, Rusha Modi, Erica Cohen, Brennan M R Spiegel. Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights. American Journal of Gastroenterology 2012; 107(10) doi: 10.1038/ajg.2012.194
26
Carmelo Scarpignato, Giovanni Barbara, Angel Lanas, Lisa L. Strate. Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818771305
27
Alexandra M. Zaborowski, Des C. Winter. Evidence-based treatment strategies for acute diverticulitis. International Journal of Colorectal Disease 2021; 36(3) doi: 10.1007/s00384-020-03788-4
28
Georgia Brown, Emily C. Hoedt, Simon Keely, Ayesha Shah, Marjorie M. Walker, Gerald Holtmann, Nicholas J. Talley. Role of the duodenal microbiota in functional dyspepsia. Neurogastroenterology & Motility 2022; 34(11) doi: 10.1111/nmo.14372
29
E. SCARPELLINI, M. GABRIELLI, C. E. LAURITANO, A. LUPASCU, G. MERRA, G. CAMMAROTA, I. A. CAZZATO, G. GASBARRINI, A. GASBARRINI. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Alimentary Pharmacology & Therapeutics 2007; 25(7) doi: 10.1111/j.1365-2036.2007.03259.x
30
Yu. A. Shelygin, V. T. Ivashkin, S. I. Achkasov, A. I. Moskalev, V. M. Тimerbulatov, A. V. Sazhin, S. G. Shapovalyants, O. Y. Karpukhin, N. V. Kostenko, N. N. Кorotkikh, I. V. Zarodnyuk, J. L. Trubacheva, V. V. Veselov, A. A. Likutov, V. N. Kashnikov, S. A. Frolov, P. A. Yartsev, I. D. Loranskaya, B. A. Vykova, O. S. Shifrin, E. A. Poluektova, Z. A. Mamieva, A. I. Ulyanin, T. V. Shkurko. CLINICAL GUIDELINES Diverticular disease (57.2, 57.3), adults. Koloproktologia 2024; 23(2) doi: 10.33878/2073-7556-2024-23-2-10-27
31
Angel Lanas, Daniel Abad-Baroja, Aitor Lanas-Gimeno. Progress and challenges in the management of diverticular disease: which treatment?. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818789055
32
G. Latella. Diverticular Disease: Emerging Evidence in a Common Condition. Falk Symposium 2006; 148 doi: 10.1007/1-4020-4318-X_20
33
Hendrike E. Bolkenstein, Esther C. J. Consten, Job van der Palen, Bryan J. M. van de Wall, Ivo A. M. J. Broeders, Willem A. Bemelman, Johan F. Lange, Marja A. Boermeester, Werner A. Draaisma. Long-term Outcome of Surgery Versus Conservative Management for Recurrent and Ongoing Complaints After an Episode of Diverticulitis. Annals of Surgery 2019; 269(4) doi: 10.1097/SLA.0000000000003033
34
Brennan Spiegel. Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome. American Journal of Gastroenterology 2022; 117(12) doi: 10.14309/ajg.0000000000002066
35
Antonio Tursi. Balsalazide Plus High-potency Probiotic Preparation (VSL♯3) in the Treatment of Acute Mild-to-moderate Ulcerative Colitis and Uncomplicated Diverticulitis of the Colon. Journal of Clinical Gastroenterology 2008; 42(Supplement 3) doi: 10.1097/MCG.0b013e31815f5ac7
36
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
37
Rocco Ricciardi, Susannah Clark, Patricia L. Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019;  doi: 10.1016/B978-0-323-40232-3.00157-6
38
Antonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti, Walter Elisei. Transient Lactose Malabsorption in Patients Affected by Symptomatic Uncomplicated Diverticular Disease of the Colon. Digestive Diseases and Sciences 2006; 51(3) doi: 10.1007/s10620-006-3155-6
39
Angèle P. M. Kerckhoffs, Maarten R. Visser, Melvin Samsom, Michel E. van der Rest, Joris de Vogel, Wil Harmsen, Louis M. A. Akkermans. Critical Evaluation of Diagnosing Bacterial Overgrowth in the Proximal Small Intestine. Journal of Clinical Gastroenterology 2008; 42(10) doi: 10.1097/MCG.0b013e31818474d7
40
Doron Boltin, Tsachi Tsadok Perets, Einav Shporn, Shoshana Aizic, Sigal Levy, Yaron Niv, Ram Dickman. Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome. Annals of Clinical Microbiology and Antimicrobials 2014; 13(1) doi: 10.1186/s12941-014-0049-x
41
Bryan J M van de Wall, Marguerite A W Stam, Werner A Draaisma, R Stellato, Willem A Bemelman, Marja A Boermeester, Ivo A M J Broeders, Eric J Belgers, Boudewijn R Toorenvliet, Hubert A Prins, Esther C J Consten. Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology & Hepatology 2017; 2(1) doi: 10.1016/S2468-1253(16)30109-1
42
Antonio Tursi, Raymond E. Joseph, Paul Streck. Expanding Applications: The Potential Usage of 5-Aminosalicylic Acid in Diverticular Disease. Digestive Diseases and Sciences 2011; 56(11) doi: 10.1007/s10620-011-1731-x
43
Sanjoy Ghosh, Erin Molcan, Daniella DeCoffe, Chaunbin Dai, Deanna L. Gibson. Diets rich inn-6 PUFA induce intestinal microbial dysbiosis in aged mice. British Journal of Nutrition 2013; 110(3) doi: 10.1017/S0007114512005326
44
Antonio Tursi. Diverticulosis today: unfashionable and still under-researched. Therapeutic Advances in Gastroenterology 2016; 9(2) doi: 10.1177/1756283X15621228
45
Brennan M. R. Spiegel, Mark W. Reid, Roger Bolus, Cynthia B. Whitman, Jennifer Talley, Stanley Dea, Kamyar Shahedi, Hetal Karsan, Chassidy Teal, Gil Y. Melmed, Erica Cohen, Garth Fuller, Linnette Yen, Paul Hodgkins, M. Haim Erder. Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL. Quality of Life Research 2015; 24(1) doi: 10.1007/s11136-014-0753-1
46
Roman Maslennikov, Victoria Agarkova, Elena Poluektova, Anatoly Ulyanin, Oksana Zolnikova, Anastasia Kurbatova, Evgenii Kozlov, Tatyana Demina, Yury Zharikov, Alexey Sigidaev, Vladimir Ivashkin. Treatment of Small Intestinal Bacterial Overgrowth (SIBO) in Gastrointestinal, Hepatic, Endocrine, Neurological, and Postoperative Diseases: A Comprehensive Narrative Review. Medical Sciences 2026; 14(2) doi: 10.3390/medsci14020300
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.